Investors pour $14 million into Andrew Alliance
19.06.2018
Liquid handling robotics innovator Andrew Alliance has added leading life sciences companies to its list of backers in the series C funding round closed this week.
 |
 |
Tecan Group, the Waters Corporation, Inpeco, Rancilio Cube, Sam Eletr Trust and Omega Funds are among the investors who contributed a total of $14 million. Private equity and existing investors also participated.
Andrew Alliance’s benchtop and transportable android aims to improve the accuracy and repeatability of liquids handling tasks while reducing error and waste. “Andrew” is easy to use and bridges the gap between manual pipetting and conventional robotics.
The support of Tecan Group, a world-leading supplier of automated liquids handling solutions, and global analytical technology provider Waters Corporation underlines the startup’s standing in the industry.
Andrew Alliance received support from Venture Kick in 2011 and was on the TOP 100 Swiss Startups list in 2012, 2013 and 2014. “I’ve said before that without Venture Kick, Andrew Alliance would not have been created,” said founder Piero Zucchelli. “Seven years on we have turned that kick into a business that is relied on by top life sciences companies, and are proud that these market leaders are now part of our expanded investor team.”
Andrew Alliance’s benchtop and transportable android aims to improve the accuracy and repeatability of liquids handling tasks while reducing error and waste. “Andrew” is easy to use and bridges the gap between manual pipetting and conventional robotics.
The support of Tecan Group, a world-leading supplier of automated liquids handling solutions, and global analytical technology provider Waters Corporation underlines the startup’s standing in the industry.
Andrew Alliance received support from Venture Kick in 2011 and was on the TOP 100 Swiss Startups list in 2012, 2013 and 2014. “I’ve said before that without Venture Kick, Andrew Alliance would not have been created,” said founder Piero Zucchelli. “Seven years on we have turned that kick into a business that is relied on by top life sciences companies, and are proud that these market leaders are now part of our expanded investor team.”